This information is intended for use by health professionals
Eucalyptus Oil 100.0% v/v.
For relief of the symptoms of catarrhal colds.
For relief of the symptoms of minor muscular sprains and cramps.
1a. By inhalation from drops of oil spilled onto a handkerchief which is then sniffed.
b. By inhalation of vapour from drops of oil spilled into a bowl of hot water (50°C) 'steam inhalation' and the humid vapour inhaled.
2. As a rubefacient during massage of sprains and cramps where massage is an appropriate treatment.
Recommended Dose and Dosage Schedule
Adults, the elderly and children over 1 year:
|| Sprinkle a few drops on to a handkerchief and inhale as required.
|| A few drops into warm/hot water (50°C) and inhale the humid vapour, as required.
|| A few drops on the hand to lubricate the massage of appropriate areas as required.
Sensitivity to Eucalyptus Oil.
Not recommended for infants under 1 year.
Keep all medicines out of the reach and sight of children.
Not to be take orally.
If symptoms persist consult your doctor.
No evidence can be found as to the safety of the product in pregnancy or lactation. The use of all drugs should be avoided during the first trimester.
At the dosage indicated, no evidence can be found that the product affects the ability to drive or to use machinery.
When used as a rubefacient it may induce skin sensitisation and eczema.
No adverse effects of inhalation are reported but in sensitised individuals the precipitation of hay fever or asthma are potential unwanted effects.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Symptoms: poisoning with eucalyptus oil may cause epigastric burning, nausea and vomiting, dizziness, muscular weakness, miosis, tachycardia, a feeling of suffocation, cyanosis, ataxia, pulmonary damage, delirium, convulsions and CNS depression, including coma. Deaths have been recorded from doses as low as 3.5ml.
Emergency procedures: after ingestion the stomach should be emptied by aspiration and lavage. Demulcent drinks may be given. Large volumes of fluid should be given provided renal function is adequate. Effects of excessive inhalation should be treated by removal to fresh air.
When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient.
After ingestion excretion takes place via the lungs, skin and kidneys.
Store below 25°C.
Keep container tightly closed.
25ml: Amber glass bottle with white plastic child resistant cap with EPE/Saranex liner.
L. C. M. Ltd.